Search Results

Vystar® Corporation announces that it plans to split into two companies via a dividend. In addition to the previously announced spin-off of RxAir® air purification and Fluid Energy Conversion subsidiaries into a separate, publicly traded company, Vystar plans to add a third subsidiary, Vytex® latex and rubber, into the spin-off.

Vystar® Corporation (OTCQB: VYST) has named Byron Novosad, DDS, to the Vystar Board of Directors, effective immediately.

Vystar® Corporation’s RxAir® division has joined forces with a powerful new ally, Nothing in the Air, to market and distribute the RxAir ultraviolet light air purifier product line.

Vystar® Corporation reports milestone financial results for the first quarter of 2021 with record high revenue and profit for the first time in the company’s history.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Vystar Corporation, parent company of RxAir® UV light air purification products, Rotmans Furniture and Floor Covering, and Vytex® deproteinized rubber and latex, has managed numerous initiatives though the challenges of the COVID-19 pandemic and has emerged with a new and stronger supply chain, reliable manufacturing partners, an improved product offering and a growing market presence and distribution network.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.

Bruker Corporation announced it will present at the following conferences.